Skip to main content
. 2016 Jul 27;104(3):729–735. doi: 10.3945/ajcn.115.126359

TABLE 3.

Serum 25(OH)D concentrations in relation to fertilization rate1

2PN2/MII3 All cycles4 (n = 141) 2PN2/MII3 IVF cycles4 (n = 71) 2PN2/MII3 ICSI cycles4 (n = 70)
Serum 25(OH)D,5 nmol/L
 Q1 [65.0 (33.5–75.0)] 251/386 0.62 (0.51, 0.72) 158/235 0.63 (0.47, 0.77) 93/151 0.52 (0.36, 0.68)
 Q2 [83.1 (75.9–86.2)] 196/349 0.53 (0.43, 0.63) 119/196 0.53 (0.39, 0.67) 77/153 0.38 (0.24, 0.55)
 Q3 [92.4 (86.8–104.6)] 228/327 0.67 (0.56, 0.76) 52/95 0.50 (0.31, 0.68) 176/232 0.73 (0.59, 0.83)
 Q4 [115.0 (107.8–155.5)] 264/356 0.73 (0.63, 0.80) 137/185 0.71 (0.55, 0.83) 127/171 0.74 (0.62, 0.83)
P6 0.03 0.39 0.004
P-heterogeneity 0.05
1

n = 100 women, 141 cycles with attempted fertilization. ICSI, intracytoplasmic sperm injection; IVF, in vitro fertilization; MII, metaphase II; Q, quartile; 2PN, 2 pronuclei; 25(OH)D, 25-hydroxyvitamin D.

2

Number of oocytes with 2PN after insemination.

3

Number of oocytes in MII.

4

Values are marginal means (95% CIs) adjusted for age, BMI, infertility diagnosis, race, dietary patterns, folate, and vitamin B-12 serum concentrations.

5

Values are medians (ranges).

6

The median concentration of vitamin D in each group was used as a continuous variable in the model.